Abstract
Abstract
French
The pathogenesis, clinical manifestations, and management of adverse reactions of amphotericin B are presented. Various types of nephrotoxicity, thrombophlebitis, and anemia are described along with suggestions for their prevention and management. The management of generalized reactions such as fever, GI upset, headache, and myalgias is discussed, along with a commentary on allergic reactions. Complications associated with intrathecal administration and aerosolization of the drug are also described.
Get full access to this article
View all access options for this article.
References
1.
Kucers
A
Bennett
N.
The use of antibiotics . 2nd ed . London : William Heinemann ; 1975 : 561 –74 .
2.
Goodman
L
Gilman
A
, eds. The pharmacological basis of therapeutics . 5th ed.
New York : MacMillian ; 1975 : 1236 –8 .
3.
Gent
M
Prestegard
J.
Interaction of polyene antibiotics with lipid bilayer vesicles containing cholesterol . Biochim Biophys Acta
1976 ; 426 : 17 –30 .
4.
Ermishkin
L
Kasumov
D
Potzeluyev
V.
Single ionic channels induced in lipid bilayers by polyene antibiotics amphotericin B and nystatin . Nature
1976 ; 262 : 698 –9 .
5.
Atkinson
A
Bennett
J.
Amphotericin B pharmacokinetics in humans . Anitmicrob Agents Chemother
1978 ; 13 : 271 –6 .
6.
Block
ER
Bennett
JE
Livoti
LG
Klein
WJ
MacGregor
RR
Henderson
L.
Flucytosine and amphotericin B: Hemodialysis effects on the plasma concentration and clearance . Ann Intern Med
1974 ; 80 : 613 –7 .
7.
Feldman
HA
Hamilton
JD
Gutman
RA
, Amphotericin-B therapy in an anephric patient . Antimicrob Agents Chemother
1973 ; 4 : 302 –5 .
8.
Burgess
J
Birchall
R.
Nephrotoxicity of amphotericin B, with emphasis on changes in tubluar function . Am J Med
1972 ; 53 : 77 –84 .
9.
Douglas
J
Healy
J.
Nephrotoxic effects of amphotericin B, including renal tubular acidosis . Am J Med
1969 ; 46 : 154 –62 .
10.
Butler
W
Bennett
JE
Aling
DW
Wertlake
PT
Utz
JP
Hill
GJ
, Nephrotoxicity of amphotericin B: Early and late effects in 81 patients . Ann Intern Med
1964 ; 61 : 175 –87 .
11.
Patterson
R
Acherman
G.
Renal tubular acidosis due to amphotericin B nephrotoxicity . Arch Intern Med
1971 ; 127 : 241 –4 .
12.
Finn
JT
Cohen
LH
Steinmetz
PR
, Acidifying defect induced by amphotericin B: Comparison of bicarbonate and hydrogen ion permeabilities . Kidney Int
1977 ; 11 : 261 –6 .
13.
McCurdy
DK
Frederic
M
Elkinton
JR
, Renal tubular acidosis due to amphotericin B . N Engl J Med
1968 ; 278 : 124 –31 .
14.
Steinmetz
P
Lawson
L.
Defect in urinary acidification induced in vitro by amphotericin B . J Clin Invest
1970 ; 49 : 596 –601 .
15.
Winn
W.
Coccidioidomycoses and amphotericin B . Med Clin North Am
1963 ; 47 : 1131 –48 .
16.
Takacs
F
Tomkiewicz
Z
Merril
J.
Amphotericin B nephrotoxicity with irreversible renal failure . Ann Intern Med
1963 ; 59 : 716 –24 .
17.
Miller
H
Bates
J.
Amphotericin-B toxicity: A follow-up report of 53 patients . Ann Intern Med
1969 ; 71 : 1089 –95 .
18.
Bullock
WE
Luke
RG
Nuttall
CE
Bhathena
D.
Can mannitol reduce amphotericin B nephrotoxicity?
Antimicrob Agents Chemother
1976 ; 10 : 555 –63 .
19.
Goodpasture
HC
Voth
DW
Romig
DA
Cheng
D
Wenglin
BD
Liu
C.
Clinical correlations during amphotericin-B therapy . J Kans Med Soc
1972 ; 73 : 486 –90 .
20.
Rosch
JM
Pazin
GJ
Fireman
P.
Reduction of amphotericin B nephrotoxicity with mannitol . JAMA
1976 ; 235 : 1995 –6 .
21.
Olivero
JJ
Lozano-Mendez
J
Ghafary
EM
Eknoyan
G
Suki
WN
, Mitigation of amphotericin B nephrotoxicity by mannitol . Br Med J
1975 ; 1 : 550 –1 .
22.
Hellebusch
AA
Solama
F
Eadie
E.
The use of mannitol to reduce the nephrotoxicity of amphotericin B . Surg Gynecol Obstet
1972 ; 134 : 241 –3 .
23.
Churchill
D
Seely
J.
Nephrotoxicity associated with combined gentamicin amphotericin B therapy . Nephron
1977 ; 19 : 176 –81 .
24.
Arbuthnot
R
Dullea
A
Rippel
S.
Controlling thrombophlebitis from amphotericin B . Am J Hosp Pharm
1978 ; 35 : 129 .
25.
Utz
JP
Bennett
JE
Brandriss
MW
Butler
WT
Hill
GJ
, Amphotericin B toxicity . Ann Intern Med
1964 ; 61 : 334 –54 .
26.
Block
ER
Bennett
JE
, Stability of amphotericin B in infusion bottles . Antimicrob Agents Chemother
1973 ; 4 : 648 –9 .
27.
Winn
W.
The use of amphotericin B in the treatment of coccidioidal disease . Am J Med
1959 ; 27 : 617 –22 .
28.
Koeffler
H
Golde
D.
Amphotericin inhibition of hematopoiesis in vitro . Am J Hematol
1977 ; 3 : 57 –62 .
29.
Brandriss
MW
Wolff
SM
Moores
R
Stohlman
F.
Anemia induced by amphotericin B . JAMA
1964 ; 189 : 663 –6 .
30.
MacGregor
RR
Bennett
JE
Ersler
AJ
, Erythropoietin concentration in amphotericin B-induced anemia . Antimicrob Agents Chemother
1978 ; 14 : 270 –3 .
31.
Hickie
H
Walker
T.
Cryptococcosis (Torulosis): Some problems in diagnosis and management . Aust Ann Med
1964 ; 13 : 229 –39 .
32.
Drutz
DJ
Spickard
A
Rogers
DE
Koenig
ME
, Treatment of disseminated mycotic infections: A new approach to amphotericin-B therapy . Am J Med
1968 ; 45 : 405 –18 .
33.
Tynes
BS
Utz
JP
Bennett
JE
Alling
DW
, Reducing amphotericin B reactions . Am Rev Respir Dis
1963 ; 87 : 264 –8 .
34.
Chung
D
Koenig
M.
Reversible cardiac enlargement during treatment with amphotericin B and hydrocortisone . Am Rev Respir Dis
1971 ; 103 : 831 –41 .
35.
Kisch
AC
Maydew
RP
Evan
AP
, Synergistic nephrotoxicity of amphotericin B and cortisone acetate in mice . J Infect Dis
1978 ; 137 : 789 –94 .
36.
Andriole
V
Kravetz
H.
The use of amphotericin B in man . JAMA
1962 ; 180 : 269 –72 .
37.
Glynn
KP
Alazraki
NP
Waltz
TA
, Coccidioidal meningitis: Intrathecal treatment with hyperbaric amphotericin B . Calif Med
1973 ; 119 : 6 –9 .
38.
Alazraki
NP
Fierer
J
Halpern
SE
Becker
RW
, Use of a hyperbaric solution for administration of intrathecal amphotericin
B. N Engl J Med
1974 ; 290 : 641 –6 .
39.
Keane
J.
Cisternal puncture complications: Treatment of coccidioidal meningitis with amphotericin B . Calif Med
1973 ; 119 : 10 –15 .
40.
Witorsch
P
Williams
TW
Ommaya
AK
Utz
JP
, Intraventricular administration of amphotericin B . JAMA
1965 ; 194 : 699 –702 .
41.
Ratcheson
R
Ommaya
A.
Experience with the subcutaneous cerebrospinal fluid reservoir . N Engl J Med
1968 ; 279 : 1025 –31 .
42.
Diamond
RD
Bennett
JE
, A subcutaneous reservoir for intrathecal therapy of fungal meningitis . N Engl J Med
1973 ; 288 : 186 –8 .
43.
Murray
H.
Allergic reactions to amphotericin B (letter) . N Engl J Med.
1974 ; 290 : 693 .
44.
Swanson
M
Cook
R.
Drugs, chemicals and blood dyscrasias . Hamilton, IL : Drug Intelligence Publications , 1977 .
45.
Bennett
JE
, Allergic reactions to amphotericin B (letter) . N Engl J Med
1974 ; 290 : 693 .
46.
Carneccia
B
Kurtzke
J.
Fatal toxic reaction to amphotericin B in cryptococcal meningoencephalitis . Ann Intern Med
1960 ; 53 : 1027 –36 .
47.
Bennett
JE
, Chemotherapy of systemic mycoses . N Engl J Med
1974 ; 290 : 30 –2 , 320 –4 .
48.
Shadomy
S
Brummer
DL
Ingroff
AV
, Light sensitivity of prepared solutions of amphotericin B . Am Rev Respir Dis
1973 ; 107 : 303 –4 .
49.
Tipple
M
Shadomy
S
Espinel-Ingroff
A.
Availability of active amphotericin B after filtration through membrane filters . Am Rev Respir Dis
1977 ; 115 : 879 –81 .
50.
Barreuther
AD
Dodge
RR
Blondeaux
AM
, Administration of amphotericin B . Drug Intell Clin Pharm
1977 ; 11 : 368 –9 .
51.
Fields
BT
Bates
JH
Abernathy
RS
, Effect of rapid intravenous infusion on serum concentrations of amphotericin B . Appl Microbiol
1971 ; 22 : 615 –7 .
52.
Eisenberg
R
Oatway
W.
Nebulization of amphotericin B . Am Rev Respir Dis
1971 ; 105 : 289 –92 .